A pivotal advancement in gene therapy for hearing loss
The U.S. Food and Drug Administration (FDA) has made history by approving the first gene therapy targeting inherited deafness. This groundbreaking decision heralds a new era in the treatment of genetic hearing loss, impacting countless individuals and families affected by this condition. What happened On October 3, 2023, the FDA granted approval for a gene…










